# Integrative spatial profiling pipeline for determining TME architectures in archival clinical specimens using CmTSA superplex technology

**Authors:** Chaoxin Xiao, Ruihan Zhou, Qin Chen, Wanting Hou, Yulin Wang, Lu Liu, Huanhuan Wang, Xiaohong Yao, Rui Zhu, Zirui Wang, Leyi Yao, Ouying Yan, Xiaoying Li, Tongtong Xu, Fujun Cao, Banglei Yin, Na Xiao, Lili Jiang, Wei Wang, Dan Cao, Chengjian Zhao

PMC · DOI: 10.1038/s41421-026-00874-9 · 2026-03-10

## TL;DR

A new method called CmTSA superplex technology enables detailed analysis of tumor microenvironments in archived clinical samples, improving understanding of cancer progression and treatment response.

## Contribution

The novel hybrid optochemical fluorescence depletion (HOC-FD) technology and RNN-based spatial profiling pipeline enable high-resolution, cost-efficient TME analysis in FFPE archival tissues.

## Key findings

- HOC-FD combined with CmTSA allows 30–60 biomarker labeling in FFPE tissues with high signal-to-noise ratios.
- A deep learning pipeline enables accurate cellular segmentation and phenotype classification in TME imaging.
- Radius-constrained neighborhood networks (RNNs) reliably define functional niches with biological and prognostic relevance.

## Abstract

The tumor microenvironment (TME) comprises diverse cellular components that spatially interact to form distinct functional niches (FNs). Profiling these TME spatial features has proven to be a critical approach for correlating tumor progression and therapeutic response. However, RNA stability limitations constrain the broad clinical implementation of spatial transcriptomics, while high background noise and low signal resolution compromise the accuracy of direct labeling-based spatial proteomic approaches in clinical specimens. To overcome these constraints in archival samples, we developed hybrid optochemical fluorescence depletion (HOC-FD) technology that integrates autofluorescence quenching with cyclic multiplex tyramide signal amplification (CmTSA) for formalin-fixed paraffin-embedded (FFPE) tissues. This unified platform enables the concurrent labeling of 30–60 biomarkers with ultrahigh signal-to-noise ratios while maintaining cost efficiency and compatibility with high-throughput processing of archival FFPE specimens. While superplex imaging captures multidimensional TME data, extracting spatial features from raw pixel-level outputs remains technically challenging. To resolve this problem, we implemented a computer vision pipeline beginning with deep learning-based cellular segmentation and phenotype classification under predefined biomarker annotation rules. Using single-cell spatial mapping of human colon and cervical cancer specimens, we systematically evaluated and selected radius-constrained neighborhood network (RNN) analysis to define functional niches, validating their accuracy and reliability in generating spatially coherent FNs with biological and prognostic relevance. In summary, the CmTSA platform combined with RNN-based spatial profiling provides an integrated framework for visualizing and quantifying multicellular functional states within architectures of the TME, potentially enhancing tumor immunology investigations and precision immunotherapies.

## Linked entities

- **Diseases:** colon cancer (MONDO:0002032), cervical cancer (MONDO:0002974)

## Full-text entities

- **Genes:** PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, HAVCR2 (hepatitis A virus cellular receptor 2) [NCBI Gene 84868] {aka CD366, HAVcr-2, KIM-3, SPTCL, TIM3, TIMD-3}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TRN-GTT2-7 (tRNA-Asn (anticodon GTT) 2-7) [NCBI Gene 7214] {aka TRN, TRN1}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, CD80 (CD80 molecule) [NCBI Gene 941] {aka B7, B7-1, B7.1, BB1, CD28LG, CD28LG1}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, CD86 (CD86 molecule) [NCBI Gene 942] {aka B7-2, B7.2, B70, BU63, CD28LG2, CD86 v6}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, CTLA4 (cytotoxic T-lymphocyte associated protein 4) [NCBI Gene 1493] {aka ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}
- **Diseases:** Tumors (MESH:D009369), lung, gastric, liver, cervical, endometrial, and pancreatic cancer (MESH:D010190), cervical cancer (MESH:D002583), intrahepatic cholangiocarcinoma (MESH:D018281), TSA (MESH:C566796), colon and cervical cancer (MESH:D015179)
- **Chemicals:** EDTA (MESH:D004492), xylene (MESH:D014992), FITC (MESH:D016650), streptomycin (MESH:D013307), Paraffin (MESH:D010232), metal (MESH:D008670), HCl (MESH:D006851), aldehyde (MESH:D000447), hydroxyl radicals (MESH:D017665), ethanol (MESH:D000431), water (MESH:D014867), urea (MESH:D014508), fluorescein (MESH:D019793), H&amp;E (MESH:D006371), Alexa 488 (-), hydrogen peroxide (MESH:D006861), Hematoxylin (MESH:D006416), Alexa Fluor 647 (MESH:C569686), penicillin (MESH:D010406), hydrogen (MESH:D006859), PBS (MESH:D007854), eosin (MESH:D004801), Cy5 (MESH:C085321), DAPI (MESH:C007293), formaldehyde (MESH:D005557), l-glutamine (MESH:D005973), CO2 (MESH:D002245), TRITC (MESH:C009434), OH (MESH:C031356), PFA (MESH:C003043)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976111/full.md

---
Source: https://tomesphere.com/paper/PMC12976111